Drug-eluting or bare metal stents for the treatment of saphenous vein graft disease a bayesian meta-analysis

Circulation: Cardiovascular Interventions

Volumn 3, Issue 6, 2010, Pages 565-576

  Paradis, Jean Michel ^a   Bélisle, Patrick ^b   Joseph, Lawrence ^b   Bertrand, Olivier F ^a   DeLarochelliére, Robert ^a   Déry, Jean Pierre ^a   Larose, Éric ^a   Rodés Cabau, Josep ^a   Rinfret, Stéphane ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Bare metal stent; Drug eluting stent; Meta analysis; Saphenous vein graft

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TACROLIMUS; THIENOPYRIDINE DERIVATIVE; ZOTAROLIMUS; METAL;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BAYES THEOREM; BLOOD VESSEL DIAMETER; CHRONIC KIDNEY FAILURE; CLINICAL EFFECTIVENESS; COMPRESSION GARMENT; DEVICE SAFETY; DIABETES MELLITUS; DISEASE DURATION; DRUG ELUTING STENT; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; LEG REVASCULARIZATION; MAINTENANCE THERAPY; META ANALYSIS; MORTALITY; NEOINTIMA; OVERALL SURVIVAL; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK REDUCTION; SAMPLE SIZE; SIROLIMUS ELUTING STENT; STENT THROMBOSIS; TACROLIMUS ELUTING STENT; TREATMENT OUTCOME; VEIN GRAFT DISEASE; ZOTAROLIMUS ELUTING STENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAPHENOUS VEIN; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TRANSPLANTATION;

ANGIOPLASTY, BALLOON, CORONARY; BAYES THEOREM; DRUG-ELUTING STENTS; HUMANS; METALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAPHENOUS VEIN; STENTS;

EID: 79953292213     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.110.949735     Document Type: Article

References (41)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-626. (Pubitemid 26288642)
2. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, Thottapurathu L, Krasnicka B, Ellis N, Anderson RJ, Henderson W. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: Results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44: 2149-2156. (Pubitemid 39576034)
3. Campeau L, Lesperance J, Hermann J, Corbara F, Grondin CM, Bourassa MG. Loss of the improvement of angina between 1 and 7 years after aortocoronary bypass surgery: Correlations with changes in vein grafts and in coronary arteries. Circulation. 1979;60:1-5.
4. Hanekamp CE, Koolen JJ, Den Heijer P, Schalij MJ, Piek JJ, Bar FW, De Scheerder I, Bonnier HJ, Pijls NH. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent study. Catheter Cardiovasc Interv. 2003;60:452-457. (Pubitemid 37466749)
5. Savage MP, Douglas JS Jr, Fischman DL, Pepine CJ, King SB III, Werner JA, Bailey SR, Overlie PA, Fenton SH, Brinker JA, Leon MB, Goldberg S. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts: Saphenous Vein De Novo Trial Investigators N Engl J Med. 1997;337:740-747. (Pubitemid 27417973)
6. Weintraub WS, Jones EL, Morris DC, King SB III, Guyton RA, Craver JM. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868-877. (Pubitemid 27091527)
7. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-847.
8. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780. (Pubitemid 34586912)
9. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315-1323. (Pubitemid 37186209)
10. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME. Randomized study to assess the effectiveness of slow- and moderaterelease polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108:788-794. (Pubitemid 37022118)
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231. (Pubitemid 38067635)
12. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: Results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol. 2007;50:261-267. (Pubitemid 47039289)
13. Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S. A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial. J Am Coll Cardiol. 2009;53:919-928.
14. Goswami NJ, Gaffigan M, Berrio G, Plessa AL, Pfeiffer AM, Markwell SJ, Mishkel GJ. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: Results from the Prairie "Real World" Stent Registry. Catheter Cardiovasc Interv. 2010;75:93-100.
15. Brodie BR, Wilson H, Stuckey T, Nussbaum M, Laurent S, Bradshaw B, Humphrey A, Metzger C, Hermiller J, Krainin F, Juk S, Cheek B, Duffy P, Simonton CA. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group. J Am Coll Cardiol Cardiovasc Interv. 2009;2:1105-1112.
16. Shishehbor MH, Hawi R, Singh IM, Tuzcu EM, Bhatt DL, Ellis SG, Kapadia SR. Drug-eluting versus bare-metal stents for treating saphenous vein grafts. Am Heart J. 2009;158:637-643.
17. Assali A, Raz Y, Vaknin-Assa H, Ben-Dor I, Brosh D, Teplitsky I, Fuchs S, Kornowski R. Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions. EuroIntervention. 2008;4:108-114.
18. van Twisk PH, Daemen J, Kukreja N, van Domburg RT, Serruys PW. Four-year safety and efficacy of the unrestricted use of sirolimus- and paclitaxel-eluting stents in coronary artery bypass grafts. EuroIntervention. 2008;4:311-317.
19. Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis. Catheter Cardiovasc Interv. 2008;72:7-12. (Pubitemid 352013502)
20. Ramana RK, Ronan A, Cohoon K, Homan D, Sutherland J, Steen L, Liu J, Loeb H, Lewis BE. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease. Catheter Cardiovasc Interv. 2008;71:886-893. (Pubitemid 351951305)
21. Kaplan S, Barlis P, Kiris A, Dimopoulos K, Celik S, Di Mario C. Immediate procedural and long-term clinical outcomes following drugeluting stent implantation to ostial saphenous vein graft lesions. Acute Card Care. 2008;10:88-92. (Pubitemid 351883440)
22. Minutello RM, Bhagan S, Sharma A, Slotwiner AJ, Feldman DN, Cuomo LJ, Wong SC. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease. J Interv Cardiol. 2007;20:458-465. (Pubitemid 350179467)
23. Hoffmann R, Pohl T, Koster R, Blindt R, Boeckstegers P, Heitzer T. Implantation of paclitaxel-eluting stents in saphenous vein grafts: Clinical and angiographic follow-up results from a multicentre study. Heart. 2007;93:331-334. (Pubitemid 46579523)
24. Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, Makkar RR. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv. 2005;66:507-511. (Pubitemid 41779016)
25. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J, Montorfano M, Michev I, Airoldi F, Carlino M, Corvaja N, Colombo A. Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome. J Am Coll Cardiol. 2005;45:989-994. (Pubitemid 40432427)
26. Lozano I, Garcia-Camarero T, Carrillo P, Baz JA, de la Torre JM, Lopez-Palop R, Pinar E, Salvatella N, Avanzas P, Valdes M. Comparison of drug-eluting and bare metal stents in saphenous vein grafts: Immediate and long-term results. Rev Esp Cardiol. 2009;62:39-47.
27. Okabe T, Lindsay J, Buch AN, Steinberg DH, Roy P, Slottow TL, Smith K, Torguson R, Xue Z, Satler LF, Kent KM, Pichard AD, Weissman NJ, Waksman R. Drug-eluting stents versus bare metal stents for narrowing in saphenous vein grafts. Am J Cardiol. 2008;102:530-534.
28. Gioia G, Benassi A, Mohendra R, Chowdhury K, Masood I, Matthai W. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts. Catheter Cardiovasc Interv. 2008;72:13-20. (Pubitemid 352008974)
29. Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, Piovaccari G, Menozzi A, Percoco G, Benassi A, Rusticali G, Marzaroli P, Guastaroba P, Grilli R, Maresta A, Marzocchi A. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry). Am J Cardiol. 2008;101:947-952.
30. Bansal D, Muppidi R, Singla S, Sukhija R, Zarich S, Mehta JL, Sachdeva R. Percutaneous intervention on the saphenous vein bypass grafts: Long-term outcomes. Catheter Cardiovasc Interv. 2008;71:58-61. (Pubitemid 351158347)
31. Ellis SG, Kandzari D, Kereiakes DJ, Pichard A, Huber K, Resnic F, Yakubov S, Callahan K, Borgman M, Cohen SA. Utility of sirolimuseluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: Results of a multicenter 350-patient case-control study. J Invasive Cardiol. 2007;19:404-409. (Pubitemid 47509462)
32. Wohrle J, Nusser T, Kestler HA, Kochs M, Hombach V. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions. Clin Res Cardiol. 2007;96:70-76. (Pubitemid 46233208)
33. Chu WW, Rha SW, Kuchulakanti PK, Cheneau E, Torguson R, Pinnow E, Alexieva-Fournadjiev J, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Efficacy of sirolimus-eluting stents compared with bare metal stents for saphenous vein graft intervention. Am J Cardiol. 2006; 97:34-37. (Pubitemid 41828119)
34. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Bruining N, Van den Branden F, Van Langenhove G. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: Six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. J Am Coll Cardiol. 2006;48:2423-2431. (Pubitemid 44895571)
35. Kanei YSJ, Diwan R, Nakra NC, Lakhanpal G, Fox JT. Long-term outcome of drug-eluting stents in saphenous vein graft lesions [abstract]. Cardiovasc Revasc Med. 2008:215.
36. Latib A, Ferri L, Ielasi A, Cosgrave J, Godino C, Bonizzoni E, Romagnoli E, Chieffo A, Valgimigli M, Penzo C, Carlino M, Michev I, Sangiorgi GM, Montorfano M, Airoldi F, Colombo A. Comparison of the long-term safety and efficacy of drug-eluting and bare-metal stent implantation in saphenous vein grafts. Circ Cardiovasc Interv. 2010;3:249-256.
37. Jeger RV, Schneiter S, Kaiser C, Bonetti PO, Brunner-La Rocca H, Handke M, Osswald S, Buser PT, Pfisterer ME. Drug-eluting stents compared with bare metal stents improve late outcome after saphenous vein graft but not after large native vessel interventions. Cardiology. 2009;112:49-55.
38. Brilakis ES, Saeed B, Banerjee S. Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: A critical appraisal. J Interv Cardiol. 2008;21:151-157. (Pubitemid 351492481)
39. Eisenstein EL, Anstrom KJ, Kong DF, Shaw LK, Tuttle RH, Mark DB, Kramer JM, Harrington RA, Matchar DB, Kandzari DE, Peterson ED, Schulman KA, Califf RM. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159-168. (Pubitemid 46089732)
40. Rodes-Cabau J, Bertrand OF, Larose E, Dery JP, Rinfret S, Bagur R, Proulx G, Nguyen CM, Cote M, Landcop MC, Boudreault JR, Rouleau J, Roy L, Gleeton O, Barbeau G, Noel B, Courtis J, Dagenais GR, Despres JP, DeLarochelliere R. Comparison of plaque sealing with paclitaxeleluting stents versus medical therapy for the treatment of moderate nonsignificant saphenous vein graft lesions: The moderate vein graft lesion stenting with the taxus stent and intravascular ultrasound (VELETI) pilot trial. Circulation. 2009;120:1978-1986.
41. Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J, Fleckenstein M, Neumann FJ, Sattelberger U, Schmitt C, Muller M, Dirschinger J, Schomig A. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41:1283-1288. (Pubitemid 36438988)